Filing Details

Accession Number:
0001387131-20-007758
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-24 09:00:11
Reporting Period:
2020-08-20
Accepted Time:
2020-08-24 09:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP Pharmaceutical Preparations (2834) 261434750
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1716713 Smith Margaret Bell C/O Tonix Pharmaceuticals Holding Corp.
509 Madison Ave., Suite 306
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2020-08-20 5,391 $0.93 5,391 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9262 to $0.9273, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth herein.